SS 2017: Novel Strategies to Improve STI Screening
-
Upload
sri-lanka-college-of-sexual-health-and-hiv-medicine -
Category
Health & Medicine
-
view
39 -
download
2
Transcript of SS 2017: Novel Strategies to Improve STI Screening
![Page 1: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/1.jpg)
Novel Strategies to Improve STI Screening
Seema SoodM.D., MNAMS
Professor of MicrobiologyAll India Institute of Medical Sciences, New Delhi
![Page 2: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/2.jpg)
Background
STIs are a significant public health problem
Profound impact on sexual and reproductive health of adults
Newborn & child health
Early diagnosis is crucial
![Page 3: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/3.jpg)
WHO Estimates: Curable STIs in 2012
Source: WHO/RHR/16.09, WHO 2016
![Page 4: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/4.jpg)
Early Detection
Screening
Diagnosis
Is the best opportunity for effective treatment and for preventing further transmission
Huge variation in availability of tests
Screening remains rare in resource-limited settings
![Page 5: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/5.jpg)
Syndromic Management
Advantages
Disadvantages
Over time, it is important to move from syndromic to etiological approach
Source: WHO/RHR/16.09, WHO 2016
![Page 6: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/6.jpg)
![Page 7: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/7.jpg)
Point of care tests
Conventional
• Gram staining
• KOH mount
• Tzanck Smear
• Wet mount
• RPR
• Dark ground microscopy
Newer
• Immune-chromatography
• Optical immunoassay,
• Latex agglutination
![Page 8: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/8.jpg)
WHO-ASSURED Criteria
• Affordable A• SpecificS• SensitiveS• User-friendly U• Rapid and robustR• Equipment-free E• Delivered - to end usersD
![Page 9: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/9.jpg)
Bacterial STIs
Disease burden disproportionately affect women
Emergence & spread of AMR in NG is a global concern
Diagnostic tests with high sensitivity & specificity are
available
POCTs: syphilis
![Page 10: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/10.jpg)
Point of Care Patient Testing
Available POCTs for detection of CT or NG have low accuracy or require expensive equipment
NearPOCT: GeneXpert (Cepheid, Sunnyvale, CA, USA)
Urgent need for improved assays
New technologies
![Page 11: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/11.jpg)
Biosensor Technology
Emerging technology in Diagnostics
Provides rapid, accurate diagnosis
Offers a low detection limit
Compact instrumentation compatible with portable devices
Potential to be used as an integral component in POC test (POCT) devices
Singh R, Mukherjee MA, Sood S et al. Sensors & Actuators: B: Chemical, 2014:197: 385-404.
![Page 12: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/12.jpg)
Principle of Biosensor
Figure. (a) Schematic of a biosensor
NPG Asia Materials (2011) 3, 17–24; doi:10.1038/asiamat.2010.137
![Page 13: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/13.jpg)
Electrochemical DNA Biosensor(opa-gene)
Methylene Blue was used as hybridization monitor agent
Decrease in signal intensity was observed for dsDNA
Optimization of working conditions was done using synthetic DNA
![Page 14: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/14.jpg)
Probe sequences
Sequence NameLength
(bases)Sequence
Probe 195’S-S-C6-CGGTGCTTCATCACCTTAG
3'
Complementary
sequence19 5' CTAAGGTGATGAAGCACCG 3'
One-base
mismatch19 5' CTAAGTTGATGAAGCACCG 3'
Non-
complementary19 5' ACGGTTCACGCGGTACTTA 3'
PATENT: International Application no. PCT/IN2010/000457
![Page 15: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/15.jpg)
Overview
CV, DPV,
SEM
Preparation of
a Solid Support
Immobilization
of Probe DNA
Biosensor
Characterization
Characterization
Target DNA
Electrochemical
Signal Detection
Response
Characteristics
CV, DPV, SEMProbe DNA
Synthetic DNA
PCR Amplicons
Clinical samplesCV, DPV
![Page 16: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/16.jpg)
In-house PCR
Gene Forward primer Reverse primer PCR conditions Amplicon
size
opa
gene
5’CGGTGCTTCA
TCACCTTAG 3'
5'GGATTCATTTT
CGGCTCCTT 3'
94C for 45 s
56C for 45 s 30cycles
72C for 45 s
188 bps
Verma R, Sood S. Ind J Med Res 2016; 34(4): 560-01Verma R, Sood S*, Bala M et al. Epidemiol Infect 2012; 140(11): 2110-16
![Page 17: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/17.jpg)
PCR (Female Patients)
Methods Microscop
y
GC
Culture
PCR
Number of
Patients
1 (250) 1 (250) 17 (250)
Sood S, Verma R, Mir S et al. Ind J Med Res 2014; 140: 649-52
16 False
Negatives
![Page 18: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/18.jpg)
Selection of suitable matrix for Biosensor
Fabrication was attempted using different matrices
Gold was selected for further studies
The characteristics that met approval Sensitivity
Reproducibility
Stability
• Biosensors and Bioelectronics 2009; 24(7): 2232-38
• J Mol Recognit 2010. 23(5):472-9
• Thin Solid Films 2010; 519:1135–40
• J Biotech, 2010; 150: 357-65
• Biosensors and Bioelectronics, 2011; 26: 2967-74
• Bioelectrochemistry, 2012; 86: 30-37
• Microchimica Acta, 2012; 177(1-2): 201-10
![Page 19: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/19.jpg)
Screen-printed gold electrodes
procured from DropSens, SpainWorking Electrode
Reference Electrode (Ag)
Counter Electrode (Pt)
ConnectorElectrochemical Analyzer
Setup
![Page 20: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/20.jpg)
Fabrication of Biosensor
Verma R, Sood S, Singh R, et al. Diagn Microbiol Infect Dis. 2014; 78: 16-23
![Page 21: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/21.jpg)
-0.5 -0.4 -0.3 -0.2 -0.1 0.0
0.0
2.0µ
4.0µ
6.0µ
8.0µ
10.0µ
12.0µ
14.0µ
16.0µ
Comp DNA
Probe DNA
OBM DNA
Non-Comp DNA
curr
en
t (
A)
Potential (V)
Synthetic
DNA
Prob
e
OBM Comp
.
Non-
comp
.
Percenta
ge
Decrease
0 -38.9 40 0
Figure. Redox peaks of MB with synthetic DNA
Table. Percentage decrease of current-
synthetic DNA with respect to probe
Studies with Synthetic DNA
![Page 22: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/22.jpg)
Detection Limit with PCR amplicons
Detection Limit: 0.23 attogm/µl
-0.50 -0.45 -0.40 -0.35 -0.30 -0.25 -0.20 -0.15 -0.10
0.0
2.0µ
4.0µ
6.0µ
8.0µ
10.0µ
12.0µ
14.0µ
16.0µ
10-12
M
10-18
M
10-20
M (0.23 attogm/ul)
10-22
M
10-15
M
10-9 M
Probe DNA
cu
rre
nt
(A
)
Potential (V)
PCR amplicons
![Page 23: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/23.jpg)
Biosensor: Evaluation
Study on PCR amplicons: 26 positive and 16 negative patient samples
Study on clinical samples: 10 positives, 10 negatives
![Page 24: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/24.jpg)
ROC Analysis
Interpretation: Area under curve (accuracy)
0.90-1: Excellent
0.80-0.90: Good
0.70-0.80: Fair
0.60-0.70: Poor
0.50-0.60: Fail
Verma R, Sood S, Singh R, et al. Diagn Microbiol Infect Dis. 2014; 78: 16-23
![Page 25: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/25.jpg)
Performance characteristics
Sood S, Verma R, Singh R, et al. P4-S1.02. Sex Transm Infect. 2011, 87: A307Verma R, Sood S, Singh R, et al. Diagn Microbiol Infect Dis. 2014; 78: 16-23
![Page 26: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/26.jpg)
DNA from negative patient samples
-400 -300 -200
0
10
20
30
40
50
60
4395
12520
14536
20680
Probe
4297
16728
19497
11484
16859
8931
Negative patient samples (DNA)
Cu
rre
nt
(uA
)
Voltage (mV)
Verma R & Sood S Ind J Med Microbiol, 2016; 34(2): 139-145.
![Page 27: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/27.jpg)
DNA from positive patient samples
-0.4 -0.3 -0.2 -0.1
0.0
2.0µ
4.0µ
6.0µ
8.0µ
10.0µ
12.0µ
14.0µ
16.0µ
DNA from Patient samples (1:10 diln)
4575
9048
15399
28430
11991
4575 dil
28488
30025
Probe
Cu
rre
nt
(uA
)
Voltage (v)
-0.4 -0.3 -0.2
0.0
2.0µ
4.0µ
6.0µ
8.0µ
10.0µ
12.0µ
14.0µ
DNA from Patient samples (further diluted 1:5 times)
11991
27818
28430
28488
4728
904830025
14273
A/737
15399
4575
Probe
Cu
rre
nt
(uA
)
Voltage (V)
Verma R & Sood S Ind J Med Microbiol, 2016; 34(2): 139-145.
![Page 28: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/28.jpg)
Progress made so far ....
Coupling of DNA biosensor with PCR provides a sensitive method for specific detection of NG
Integration of biosensors with microfluidics
Direct detection from clinical samples: needs further study
![Page 29: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/29.jpg)
Priority Populations
Sex workers
MSMs
IDUs
Other vulnerable people
![Page 30: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/30.jpg)
![Page 31: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/31.jpg)
Communication technologies
e-health (electronic-health)
STD Tracker
m-health (mobile-health)
![Page 32: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/32.jpg)
Challenges
Prevalence of disease influences PPV of the tests
There is the potential that organisms can evolve to evade detection by NAATs
nvCT
NG isolates lacking porA pseudogene
There are no assays that detect gonococcal AMR
Sample preparation
![Page 33: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/33.jpg)
Conclusion
There have been significant changes in the field of testing for STIs
Novel testing technologies combined with modern communication systems will have clinical & public health impact
![Page 34: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/34.jpg)
Acknowledgement
Sincere thanks to DBT, GOI for financial assistance (BT/PR7667/MED/14/1057 & T/PR12530/MED/32/385/2015
Prof. (Dr.) BD Malhotra Deptt. Of Biotechnology DTU, Delhi
Prof.(Dr.) V.K. Sharma Deptt. of Dermatology &
Venereology, AIIMS Prof (Dr.) Somesh Gupta Deptt. of Dermatology &
Venereology, AIIMS
Dr. Sumana Scientist E, NPL, New Delhi Dr. Rachna Verma
& Dr. Renu Singh
![Page 35: SS 2017: Novel Strategies to Improve STI Screening](https://reader031.fdocuments.net/reader031/viewer/2022030318/5a64a7ed7f8b9a27568b84d9/html5/thumbnails/35.jpg)
Thank You